Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Jacques Gonvers

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Swiss Medical Weekly|November 20, 2003
Twenty-four vs. forty-eight weeks of re-therapy with interferon alpha 2b and ribavirin in interferon alpha monotherapy relapsers with chronic hepatitis CBarbara S E August-Jörg, Jan Borovicka, Jean-François Dufour, et al.
Journal of Crohn'S & Colitis|December 22, 2010
Appropriate therapy for fistulizing and fibrostenotic Crohn's disease: Results of a multidisciplinary expert panel - EPACT IIChristian Felley, John-Paul Vader, Pascal Juillerat, et al.
Journal of Crohn'S & Colitis|December 22, 2010
Appropriate management of special situations in Crohn's disease (upper gastro-intestinal; extra-intestinal manifestations; drug safety during pregnancy and breastfeeding): Results of a multidisciplinary international expert panel-EPACT IIChristian Mottet, John-Paul Vader, Christian Felley, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 3, 2007
Connective tissue growth factor, steatosis and fibrosis in patients with chronic hepatitis CCaroline Hora, Francesco Negro, Giacchino Leandro, et al.
Journal of Crohn'S & Colitis|December 22, 2010
Appropriate maintenance treatment for Crohn's disease: Results of a multidisciplinary international expert panel - EPACT IIPascal Juillerat, John-Paul Vader, Christian Felley, et al.
Hepatology (Baltimore, Md.)|February 5, 2002
Interferon and amantadine in naive chronic hepatitis C: a double-blind, randomized, placebo-controlled trialBeat Helbling, Ivan Stamenic, Francesco Viani, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 13, 2006
Randomized placebo-controlled trial of ursodeoxycholic acid with vitamin e in nonalcoholic steatohepatitisJean-François Dufour, Carl M Oneta, Jean-Jacques Gonvers, et al.
Scandinavian Journal of Gastroenterology|July 27, 2010
Appropriateness of early management of newly diagnosed Crohn's disease in a European population-based cohortPascal Juillerat, Valérie Pittet, Christian Mottet, et al.
Journal of Crohn'S & Colitis|December 22, 2010
Appropriateness of therapy for active Crohn's disease: Results of a multidisciplinary international expert panel-EPACT IIPierre Michetti, Marc Stelle, Pascal Juillerat, et al.
European Journal of Gastroenterology & Hepatology|October 23, 2010
Infliximab for Crohn's disease in the Swiss IBD Cohort Study: clinical management and appropriatenessPascal Juillerat, Valérie Pittet, John-Paul Vader, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Swiss Medical Weekly|November 20, 2003
Twenty-four vs. forty-eight weeks of re-therapy with interferon alpha 2b and ribavirin in interferon alpha monotherapy relapsers with chronic hepatitis CBarbara S E August-Jörg, Jan Borovicka, Jean-François Dufour, et al.
Journal of Crohn'S & Colitis|December 22, 2010
Appropriate therapy for fistulizing and fibrostenotic Crohn's disease: Results of a multidisciplinary expert panel - EPACT IIChristian Felley, John-Paul Vader, Pascal Juillerat, et al.
Journal of Crohn'S & Colitis|December 22, 2010
Appropriate management of special situations in Crohn's disease (upper gastro-intestinal; extra-intestinal manifestations; drug safety during pregnancy and breastfeeding): Results of a multidisciplinary international expert panel-EPACT IIChristian Mottet, John-Paul Vader, Christian Felley, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 3, 2007
Connective tissue growth factor, steatosis and fibrosis in patients with chronic hepatitis CCaroline Hora, Francesco Negro, Giacchino Leandro, et al.
Journal of Crohn'S & Colitis|December 22, 2010
Appropriate maintenance treatment for Crohn's disease: Results of a multidisciplinary international expert panel - EPACT IIPascal Juillerat, John-Paul Vader, Christian Felley, et al.
Hepatology (Baltimore, Md.)|February 5, 2002
Interferon and amantadine in naive chronic hepatitis C: a double-blind, randomized, placebo-controlled trialBeat Helbling, Ivan Stamenic, Francesco Viani, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 13, 2006
Randomized placebo-controlled trial of ursodeoxycholic acid with vitamin e in nonalcoholic steatohepatitisJean-François Dufour, Carl M Oneta, Jean-Jacques Gonvers, et al.
Scandinavian Journal of Gastroenterology|July 27, 2010
Appropriateness of early management of newly diagnosed Crohn's disease in a European population-based cohortPascal Juillerat, Valérie Pittet, Christian Mottet, et al.
Journal of Crohn'S & Colitis|December 22, 2010
Appropriateness of therapy for active Crohn's disease: Results of a multidisciplinary international expert panel-EPACT IIPierre Michetti, Marc Stelle, Pascal Juillerat, et al.
European Journal of Gastroenterology & Hepatology|October 23, 2010
Infliximab for Crohn's disease in the Swiss IBD Cohort Study: clinical management and appropriatenessPascal Juillerat, Valérie Pittet, John-Paul Vader, et al.
Pageof 6